Katrina Goddard is Distinguished Investigator and Associate Director of the Science Programs at Kaiser Permanente Center for Health Research in Portland, OR. Katrina is genetic epidemiologist who focuses on public health genomics and the translation of genetic testing into practice. Prior to joining the Kaiser Permanente Center for Health Research in 2007, she was faculty in the Department of Epidemiology and Biostatistics (now Population and Quantitative Health Sciences) at Case Western Reserve University in Cleveland, OH. She was also a mid-career fellow at the Centers for Disease Control and Prevention in Genetics & Public Health Research and Practice. At Kaiser, she was the founding director for the NW Biobank, and she is currently a PI of Kaiser's Cancer Health Assessments Reaching Many (CHARM) study as part of the National Human Genome Research Institute (NHGRI)-funded Clinical Sequencing Evidence-Generating Research (CSER2) consortium.
- Liles, EG, Leo, MC, Freed, AS, Porter, KM, Zepp, JM, Kauffman, TL, Keast, E, McMullen, CK, Gruß, I, Biesecker, BB et al.. ORCA, a values-based decision aid for selecting additional findings from genomic sequencing in adults: Efficacy results from a randomized trial. Genet Med 2022; : . PubMed PMID:35522237 .
- Crain, PR, Zepp, JM, Gille, S, Jenkins, L, Kauffman, TL, Shuster, E, Goddard, KAB, Wilfond, BS, Hunter, JE. Identifying patients with Lynch syndrome using a universal tumor screening program in an integrated healthcare system. Hered Cancer Clin Pract 2022; 20 (1): 17. PubMed PMID:35436948 PubMed Central PMC9014602.
- Goddard, KAB, Lee, K, Buchanan, AH, Powell, BC, Hunter, JE. Establishing the Medical Actionability of Genomic Variants. Annu Rev Genomics Hum Genet 2022; : . PubMed PMID:35363504 .
- Gander, JC, Maiyani, M, White, LL, Sterrett, AT, Güney, B, Pawloski, PA, DeFor, T, Olsen, Y, Rybicki, BA, Neslund-Dudas, C et al.. Developing an algorithm across integrated healthcare systems to identify a history of cancer using electronic medical records. J Am Med Inform Assoc 2022; : . PubMed PMID:35348718 .
- Hunter, JE, Jenkins, CL, Bulkley, JE, Gilmore, MJ, Lee, K, Pak, CM, Wallace, KE, Buchanan, AH, Foreman, AKM, Freed, AS et al.. ClinGen's Pediatric Actionability Working Group: Clinical actionability of secondary findings from genome-scale sequencing in children and adolescents. Genet Med 2022; : . PubMed PMID:35341655 .
- Amendola, LM, Shuster, E, Leo, MC, Dorschner, MO, Rolf, BA, Shirts, BH, Gilmore, MJ, Okuyama, S, Zepp, JM, Kauffman, TL et al.. Laboratory-related outcomes from integrating an accessible delivery model for hereditary cancer risk assessment and genetic testing in populations with barriers to access. Genet Med 2022; : . PubMed PMID:35305866 .
- Muessig, KR, Zepp, JM, Keast, E, Shuster, EE, Reyes, AA, Arnold, B, Ingphakorn, C, Gilmore, MJ, Kauffman, TL, Hunter, JE et al.. Retrospective assessment of barriers and access to genetic services for hereditary cancer syndromes in an integrated health care delivery system. Hered Cancer Clin Pract 2022; 20 (1): 7. PubMed PMID:35144679 PubMed Central PMC8832647.
- Mittendorf, KF, Kauffman, TL, Amendola, LM, Anderson, KP, Biesecker, BB, Dorschner, MO, Duenas, DM, Eubanks, DJ, Feigelson, HS, Gilmore, MJ et al.. Corrigendum to "Cancer Health Assessments Reaching Many (CHARM): A clinical trial assessing a multimodal cancer genetics services delivery program and its impact on diverse populations" [Contemporary Clinical Trials 106 (2021) 106432]. Contemp Clin Trials 2022; 114 : 106682. PubMed PMID:35123916 .
- Duenas, DM, Shipman, KJ, Porter, KM, Shuster, E, Guerra, C, Reyes, A, Kauffman, TL, Hunter, JE, Goddard, KAB, Wilfond, BS et al.. Motivations and concerns of patients considering participation in an implementation study of a hereditary cancer risk assessment program in diverse primary care settings. Genet Med 2022; 24 (3): 610-621. PubMed PMID:34906471 PubMed Central PMC8939763.
- Mittendorf, KF, Knerr, S, Kauffman, TL, Lindberg, NM, Anderson, KP, Feigelson, HS, Gilmore, MJ, Hunter, JE, Joseph, G, Kraft, SA et al.. Systemic Barriers to Risk-Reducing Interventions for Hereditary Cancer Syndromes: Implications for Health Care Inequities. JCO Precis Oncol 2021; 5 : . PubMed PMID:34778694 PubMed Central PMC8585306.